SlideShare a Scribd company logo
1 of 6
GINA R. DIGUGLIELMO Long Valley, NJ | 862.452.1949 | ginadiguglielmo@comcast.net
CAREER HIGHLIGHTS
 Managed budgets of up to $10MM and trials of up to 1,300 Pts.
 Developed R&D training content utilized by thousands of individuals across US, Europe, and Emerging Markets.
 Lead Process Improvement Initiatives that reduced time by 50% and resourcing costs by 30%.
 Business Leader on initiatives that increased user productivity by 25% and compliance to regulators by 80%.
 Developed training content for off-shoring, and global clinical operations across 20 countries.
EXPERIENCE
Pharmaceutical & Healthcare Consultants Inc., Long Valley, NJ
Owner / Independent Consultant
March 2011 – Present
• Independent Clinical Research Consultant for Pharmaceutical, Biotech, Device, Consumer, and Clinical Research
Organizations (CROs); specializing in Clinical Research Operations and Project Management.
• Managed 5 direct reports and budgets of up to $1MM for studies of up to 400 participants.
• Execute short and long term assignment in areas of clinical development and clinical operations.
• Expertise: Project management, trial recruitment, budget management, trial metrics, training, vendor management,
process improvement initiatives, Key Opinion Leader (KOL) development
Novartis Pharmaceuticals, East Hanover, NJ
May 2004 – February 2011
Novartis Global Clinical Development & Medical Affairs Drug Safety & Epidemiology
Associate Director Medical Safety Operations
November 2009 – February 2011
• Served as Project leader on process improvement projects for clinical drug safety operations; reduced resourcing
costs by 30% and time by 50% while increasing user productivity by 25% and compliance to regulators by 80%.
• Managed global cross functional teams of 2-20.
• Led off-shoring activities for all products requiring ASR/DSUR; approximately 80 compounds.
• Developed and conducted training programs for medical safety staff and other relevant line functions within Clinical
Development and Novartis Pharma worldwide; trained groups of 200+.
• Designed roll-out strategies, training, and corporate communications on project initiatives reaching thousands of R&D
employees in 16 countries.
• Identified regulatory deficiencies in cross-functional clinical safety documents; SOPs, and databases
• Evaluated processes, SOPs, tools and databases to identify potential improvements for changes in global regulatory
requirements and corporate initiatives.
• Updated SOPs, guidance documents, tools, manuals, and training guides for global initiatives.
• Liaised with Clinical & Safety VPs to ensure continuous improvement of activities through knowledge sharing and
integration of learning.
• Led outsourcing initiative of medical writing and document Quality Control (QC) to Novartis India.
• Identified, evaluated, and managed CROs, vendors, KOLs, and consultants for process improvement initiatives.
• Identified appropriate external medical advisors to review Risk Management of Novartis products.
• Designed, implemented, and developed meeting content and presentations for Advisory Board meetings
GINA R. DIGUGLIELMO Long Valley, NJ | 862.452.1949 | ginadiguglielmo@comcast.net
• Assigned Projects : Annual Safety Reports (ASR); Development Safety Update Report (DSUR); Hepatotoxicity
Guidelines & Data Collection Tools; Novartis Advisory Boards for Optimizing Safety Risk Management
Novartis Global Clinical Development & Medical Affairs
Integrated Medical Safety
Director Integrated Safety, Methods, and Innovation
February 2008- October 2009
• Promoted to Project Leader on clinical and safety document process improvement initiatives.
• Identified and evaluated process, tool, and database deficiencies; collaborated with cross functional teams and
subject matter experts to develop solutions.
• Presented evaluations and proposed solutions to senior leadership at board meetings.
• Led assigned project teams on initiatives to develop, pilot, and implement new processes, methodology, and tools to
support clinical and drug safety document compilation.
• Developed, conducted, and implemented training programs for medical safety staff and other relevant line functions
within US and Global Clinical Development on new processes, documents, tools and methods
• Liaised with Therapeutic Area VPs to ensure continuous improvement of activities through knowledge sharing and
integration of learning.
• Developing roll-out strategies and distributing corporate communications on project initiatives throughout the global
organization.
• Supported the establishment of SOPs, KPIs, metrics, quality standards, and associated monitoring tools to ensure
compliance and quality management of redesigned processes.
Novartis Clinical Development & Medical Affairs - Arthritis, Bone, GI, Urology, Neuroscience, Ophthalmic
Associate Director Project Management & Strategic Planning
March 2006 - February 2008
• Promoted to Associate Director Project Management for US Phase I-IV trials on Arthritis, Osteoporosis, Herpes,
Parkinson’s disease, Alzheimer’s Disease, Muckle-Wells Syndrome, Macular Degeneration, and various GI
indications.
• Managed the feasibility and evaluation of new clinical programs, agreement of project timelines & deliverables,
investigator selection, resources assessment, budget management and tracking, and troubleshooting of study issues;
escalated project changes to senior management.
• Liaised between global and local clinical trial operations groups, therapeutic area physicians, field scientific
operations, marketing, health economics, statistics, data management, and other departments.
• Planned, managed, and coordinated project team activities to ensure that US trials met or exceeded objectives.
• Developed strategic US recruitment plans to ensure that the US patient commitments were met.
• Created New Ophan indications and best practice guides for recruitment in niche indications.
• Designed and evaluated CRO & vendor proposals, contracts, budget, and deliverables.
• Presented project updates to senior management at US and Global Therapeutic Area Operation meetings,
International Project Teams, Therapeutic Area Boards, and Clinical Operation Review meetings.
• Departmental Responsibilities: Train & mentor Project Managers and Local Trial Leaders on operational aspects of
clinical projects & processes; Super user and trainer for Master Investigator Database (MIDB); Project team lead on
CRA development plan initiatives; Project team lead on trial feasibility task force; Project Lead for GI & NS Medical
Product Teams; US Clinical Operation Lead for Zelnorm adjudication and SAE reconciliation project for FDA recall
Novartis
US Clinical Development & Medical Affairs - Arthritis, Bone, GI, Urology
Project Manager
May 2004- February 2006
• Recruited to lead as Clinical Operations Project Manager for US Phase I-IV trials on Arthritis, Osteoporosis, Herpes,
and various GI indications.
GINA R. DIGUGLIELMO Long Valley, NJ | 862.452.1949 | ginadiguglielmo@comcast.net
• Led the feasibility and evaluation of new clinical programs, agreement of project timelines and deliverables,
investigator selection, resources assessment, budget management and tracking, and troubleshooting of study issues;
escalated project changes to senior management.
• Liaised between global and local clinical trial operations groups, therapeutic area physicians, field scientific
operations, marketing, health economics, statistics, data management, and other departments.
(Project Manager Continued)
• Planned, managed, and coordinated project team activities to ensure that US trials met or exceeded objectives.
• Developed strategic US recruitment plans to ensure that the US patient commitments were met.
• Designed and evaluated CRO and vendor proposals, contracts, budget, and deliverables.
• Presented project updates at US and Global Therapeutic Area Operation meetings, International Project Teams,
Therapeutic Area Boards, and Clinical Operation Review meetings.
• Departmental Responsibilities: Train and mentor Project Managers and Local Trial Leaders on operational aspects
of clinical projects & processes; Project team member for developing the Master Investigator Database (MIDB);
Project team member on developing the Project Manager workload resource tool; Project Lead for GI Medical
Product Teams
Ethicon, Inc. (a division of Johnson & Johnson) – Somerville, NJ
Global Medical Affairs
Senior Project Manager - Sutures, Needles, Mesh, Dermabond, Endoscopic Vessel Harvest Products
October 2002 – April 2004
• Led Global Project Management for pre/post-marketing studies on Ethicon and Cardiovations products across the
US, EU, South Africa, and China.
• Managed studies regulated under IDE, 510k, PMA, and European registrations.
• Designed protocols for new indications, marketing claims, and next generation medical devices/surgical products.
• Collaborated with product engineers, veterinarians, marketing, sales, and statistics to develop desired outcomes.
• Developed Protocols, CRFs, Study Guides, and other relevant documents for assigned trials.
• Designed and initiated product packaging/shipping, database and statistical plans.
• Evaluated, identified, and managed CROs for the conduct of clinical studies.
• Prepared and negotiated contracts and budgets with CROs, Consultants, and KOL Surgeons.
• Ensured vendor adherence to contracts, budgets, timelines, and regulations.
• Collaborated with statisticians to format safety and efficacy listings, tables, and figures for clinical data to be
published and/or submitted to the US and Global Health Authorities.
• Departmental responsibilities: Project team member for developing the departmental Lean Process Map (Process
Excellence/Six Sigma); Project team member on the Clinical Trial Document Management System integration
(CTDMS/TrialMinder®
)
Bayer Consumer Care – Morristown, NJ
Medical Affairs & Clinical Research
Manager, Clinical Research – Aspirin, Aleve, and Alka-Seltzer
October 2000 - October 2002
• US Clinical Manager for global Phase I-IV Analgesic and Effervescent product lines, each generating $1B+ in sales.
• Designed protocols for new indications, new formulations, and marketing claims for Aspirin and Alka-Seltzer (base
brands and line extensions).
• Designed and implemented Pharmacokinetic Phase I inpatient studies.
• Developed Protocols, CRFs, Study Guides, and other relevant documents for assigned trials.
• Designed and Set-up product packaging/shipping, database and statistical plans.
• Evaluated, identified, and managed CROs for the conduct of clinical studies.
• Prepared and negotiated contracts and budgets with CROs, Consultants, Labs, and Statisticians
• Ensured vendor adherence to contracts, budgets, timelines, and regulations.
GINA R. DIGUGLIELMO Long Valley, NJ | 862.452.1949 | ginadiguglielmo@comcast.net
• Collaborated with statisticians to format safety and efficacy listings, tables, and figures for clinical data to be
published and/or submitted to the US and Global Health Authorities.
• Departmental Responsibilities: Develop clinical operation strategies; Write/amend SOPs; Project team member
for the implementation of Documentum; Project team member for the evaluation of Web-based clinical trials software
systems; Develop guidelines and procedures for departmental training guides
Pharmaceutical & Healthcare Consultants – Walworth, NY
Owner / Independent Clinical Research Consultant
January 1999 – October 2000
• Hired to serve as Regional Project Manager/Consultant for CRO and Pharmaceutical Companies.
• Managed all areas of clinical research, including but not limited to Protocol development, CRF design, investigator
selection, SAE compilation/tracking, Study Manual development, and QA auditing.
• Managed and trained field CRAs; conducted performance evaluations, monitored and assessed work load issues,
and reviewed and approved Monitoring and Expense reports.
• Therapeutic Areas/Indications: Cardiology, Endocrinology, Diabetes, Anti-Obesity, Hypertension for Phase II-III
Covance , Princeton, NJ
Regional Monitoring Network – Clinical Research – Based in Naples, FL
Sr. Regional Clinical Research Associate/Project Lead /Manager
June 1994 – January 1999
• Trained and supervised Regional CRAs for a given project, and for the site management of clinical trials in Florida.
• Managed of all aspects of clinical research for assigned region including, but not limited to budgets, study supplies,
SAEs, CRFs, Data Management, QA audits, investigator site selection, initiating, monitoring, and close-outs of
studies on a variety of therapeutic agents.
• Maintained regular communication with project teams and sponsors.
• Project Responsibilities: US Phase I-IV trials within the following Indications and Diseases - Cardiology, Neurology,
Pulmonology, Endocrinology, Rheumatology, Oncology, Osteoporosis, COPD, Diabetes, Anti-Obesity, Influenza,
CHF, Hypertension, Post-Menopausal/HRT, Parkinson’s Disease, Alzheimer’s Disease, Stroke, HA/Migraine, and
Pain Management for Cancer and Chronic Back Pain
• Departmental Responsibilities: Train and mentor Regional CRAs; Review and approve monitoring reports;
develop training manuals and guidelines for regional staff; develop liaison relationships with therapeutic project
teams and sponsors
Hoffmann-La Roche, Nutley, NJ
International Clinical Research – Therapeutic Area- CNS
Sr. Clinical Research Associate
July 1991 - June 1994
• Coordinated and managed diverse aspects of Global Clinical Trials for Parkinson’s Disease studies Phases I-III.
• Organized and participated in the initiation, monitoring, and closeout of global studies.
• Collected, reviewed, and validated data generated to ensure accuracy and compliance with study protocols.
• Designed and coordinated drug packaging and distribution for US and Global clinical trials
• Collaborated on protocol and case report development.
• Developed and designed patient brochures, press releases, and consent forms.
• Supported the planning and execution of multi-center meetings; led all presentation activities.
• Prepared efficacy results and data for inclusion in NDA submissions.
• Aided medical monitor in Adverse Event tracking and coding in the ClinTrace Database.
• Departmental Responsibilities: Train and mentor junior CRAs on Parkinson trials and departmental policies;
Project team member that redesigned CRF templates and forms to streamline clinical trial data entry processes;
Project team member on pilot Electronic Data Capture (EDC) fax scanning system
GINA R. DIGUGLIELMO Long Valley, NJ | 862.452.1949 | ginadiguglielmo@comcast.net
Hoffmann-La Roche - Nutley, NJ
Pharmaceutical Research & Quality Control – Research Products & Biotechnology
Associate Scientist - R&D April 1989 - June 1991
Assistant Scientist – QC June 1988 - April 1989
• Associate Scientist in R&D - Developed, optimized, and validated analytical methods for testing a variety of
developmental drug candidates. Analyzed clinical supplies using analytical instrumentation. Collected and evaluated
data and procedures for inclusion in IND/NDA submissions and in the USP. Prepared written procedures and
protocols to support IND/NDA submissions.
• Assistant Scientist in QC - Ensured the quality and purity of marketed dosage forms. Monitored the stability of
marketed pharmaceutical products. Performed testing and evaluated data from analytical methods to ensure
product’s release for human consumption.
EDUCATION
BS, Chemistry, Fordham University, Bronx, NY
CERTIFICATIONS
Project Management Certification Course, George Washington University, 2005 – 2007
Green Belt, Lean Methodology, J&J Process Excellence/Six Sigma, 2003
Certified Clinical Research Associate, Certification Number A98-259, ACRP, 1998 – 2006
Licensed Realtor, NJ Department of Banking & Insurance, 2011 – Present
Real Estate Sales Training, Weichert University, 2011
PROFESSIONAL MEMBERSHIPS
Drug Information Association (DIA), 1991 – Present
Association of Clinical Research Professionals (ACRP), 1991 – 2006
Fordham University Alumni Club, 1988 – Present
PUBLICATIONS
Effect of Lazabemide on the Progression of Disability in Early Parkinson's Disease
Annals of Neurology – July 1996
COMPUTER PROFICIENCIES
Microsoft Excel, Word, PowerPoint, Outlook & Visio
GINA R. DIGUGLIELMO Long Valley, NJ | 862.452.1949 | ginadiguglielmo@comcast.net
Hoffmann-La Roche - Nutley, NJ
Pharmaceutical Research & Quality Control – Research Products & Biotechnology
Associate Scientist - R&D April 1989 - June 1991
Assistant Scientist – QC June 1988 - April 1989
• Associate Scientist in R&D - Developed, optimized, and validated analytical methods for testing a variety of
developmental drug candidates. Analyzed clinical supplies using analytical instrumentation. Collected and evaluated
data and procedures for inclusion in IND/NDA submissions and in the USP. Prepared written procedures and
protocols to support IND/NDA submissions.
• Assistant Scientist in QC - Ensured the quality and purity of marketed dosage forms. Monitored the stability of
marketed pharmaceutical products. Performed testing and evaluated data from analytical methods to ensure
product’s release for human consumption.
EDUCATION
BS, Chemistry, Fordham University, Bronx, NY
CERTIFICATIONS
Project Management Certification Course, George Washington University, 2005 – 2007
Green Belt, Lean Methodology, J&J Process Excellence/Six Sigma, 2003
Certified Clinical Research Associate, Certification Number A98-259, ACRP, 1998 – 2006
Licensed Realtor, NJ Department of Banking & Insurance, 2011 – Present
Real Estate Sales Training, Weichert University, 2011
PROFESSIONAL MEMBERSHIPS
Drug Information Association (DIA), 1991 – Present
Association of Clinical Research Professionals (ACRP), 1991 – 2006
Fordham University Alumni Club, 1988 – Present
PUBLICATIONS
Effect of Lazabemide on the Progression of Disability in Early Parkinson's Disease
Annals of Neurology – July 1996
COMPUTER PROFICIENCIES
Microsoft Excel, Word, PowerPoint, Outlook & Visio

More Related Content

What's hot

ExL Pharma Clinical Trials Phase I and Phase IIa Conference Brochure: Phase 1...
ExL Pharma Clinical Trials Phase I and Phase IIa Conference Brochure: Phase 1...ExL Pharma Clinical Trials Phase I and Phase IIa Conference Brochure: Phase 1...
ExL Pharma Clinical Trials Phase I and Phase IIa Conference Brochure: Phase 1...bryonmain
 
Supervision, monitoring and evaluation of research
Supervision, monitoring and evaluation of researchSupervision, monitoring and evaluation of research
Supervision, monitoring and evaluation of researchAshok Pandey
 
Robert E. Parson Resume
Robert E. Parson ResumeRobert E. Parson Resume
Robert E. Parson Resumebpstat
 
Nidhi Rai_CV
Nidhi Rai_CVNidhi Rai_CV
Nidhi Rai_CVNidhi Rai
 
Part 3: Rare Disease Clinical Development – Strategies for Ensuring Endpoint ...
Part 3: Rare Disease Clinical Development – Strategies for Ensuring Endpoint ...Part 3: Rare Disease Clinical Development – Strategies for Ensuring Endpoint ...
Part 3: Rare Disease Clinical Development – Strategies for Ensuring Endpoint ...Medpace
 
Considerations for the Next Wave of COVID-19 Development
Considerations for the Next Wave of COVID-19 DevelopmentConsiderations for the Next Wave of COVID-19 Development
Considerations for the Next Wave of COVID-19 DevelopmentMedpace
 
COVID-19 Product Development and Clinical Trials: Considerations from Europea...
COVID-19 Product Development and Clinical Trials: Considerations from Europea...COVID-19 Product Development and Clinical Trials: Considerations from Europea...
COVID-19 Product Development and Clinical Trials: Considerations from Europea...Medpace
 
Andresen resume -emb.2105
Andresen resume -emb.2105Andresen resume -emb.2105
Andresen resume -emb.2105Paul Andresen
 
Michelle ONeal-CV 01Mar16
Michelle ONeal-CV 01Mar16Michelle ONeal-CV 01Mar16
Michelle ONeal-CV 01Mar16Michelle O'Neal
 
CV_Sandra Frazilus MAY2015
CV_Sandra Frazilus MAY2015CV_Sandra Frazilus MAY2015
CV_Sandra Frazilus MAY2015Sandra Frazilus
 
Critical Path Initiative Challenges
Critical  Path  Initiative  ChallengesCritical  Path  Initiative  Challenges
Critical Path Initiative ChallengesLandmark
 
gkaur_Resume_CMA
gkaur_Resume_CMAgkaur_Resume_CMA
gkaur_Resume_CMAGagan Kaur
 
Project management in clinical research sanjay akhani 8 may
Project management in clinical research sanjay akhani 8 mayProject management in clinical research sanjay akhani 8 may
Project management in clinical research sanjay akhani 8 maySanjay Akhani
 
Centralized vs. Onsite Monitoring
Centralized vs. Onsite MonitoringCentralized vs. Onsite Monitoring
Centralized vs. Onsite MonitoringIMARC Research
 

What's hot (20)

ExL Pharma Clinical Trials Phase I and Phase IIa Conference Brochure: Phase 1...
ExL Pharma Clinical Trials Phase I and Phase IIa Conference Brochure: Phase 1...ExL Pharma Clinical Trials Phase I and Phase IIa Conference Brochure: Phase 1...
ExL Pharma Clinical Trials Phase I and Phase IIa Conference Brochure: Phase 1...
 
Supervision, monitoring and evaluation of research
Supervision, monitoring and evaluation of researchSupervision, monitoring and evaluation of research
Supervision, monitoring and evaluation of research
 
Robert E. Parson Resume
Robert E. Parson ResumeRobert E. Parson Resume
Robert E. Parson Resume
 
Nidhi Rai_CV
Nidhi Rai_CVNidhi Rai_CV
Nidhi Rai_CV
 
Part 3: Rare Disease Clinical Development – Strategies for Ensuring Endpoint ...
Part 3: Rare Disease Clinical Development – Strategies for Ensuring Endpoint ...Part 3: Rare Disease Clinical Development – Strategies for Ensuring Endpoint ...
Part 3: Rare Disease Clinical Development – Strategies for Ensuring Endpoint ...
 
CPG ADAPTATION METHODOLOGY
CPG ADAPTATION METHODOLOGYCPG ADAPTATION METHODOLOGY
CPG ADAPTATION METHODOLOGY
 
Considerations for the Next Wave of COVID-19 Development
Considerations for the Next Wave of COVID-19 DevelopmentConsiderations for the Next Wave of COVID-19 Development
Considerations for the Next Wave of COVID-19 Development
 
Abosede salami 2014 cra
Abosede salami 2014 craAbosede salami 2014 cra
Abosede salami 2014 cra
 
PKingsby CV 19APR2016
PKingsby CV 19APR2016PKingsby CV 19APR2016
PKingsby CV 19APR2016
 
COVID-19 Product Development and Clinical Trials: Considerations from Europea...
COVID-19 Product Development and Clinical Trials: Considerations from Europea...COVID-19 Product Development and Clinical Trials: Considerations from Europea...
COVID-19 Product Development and Clinical Trials: Considerations from Europea...
 
CV_Lucinda_Fasig_BS, RN
CV_Lucinda_Fasig_BS, RNCV_Lucinda_Fasig_BS, RN
CV_Lucinda_Fasig_BS, RN
 
PJA Resume 2016
PJA Resume 2016PJA Resume 2016
PJA Resume 2016
 
Andresen resume -emb.2105
Andresen resume -emb.2105Andresen resume -emb.2105
Andresen resume -emb.2105
 
Michelle ONeal-CV 01Mar16
Michelle ONeal-CV 01Mar16Michelle ONeal-CV 01Mar16
Michelle ONeal-CV 01Mar16
 
NAAF Patient-Reported Outcomes Consortium
NAAF Patient-Reported Outcomes ConsortiumNAAF Patient-Reported Outcomes Consortium
NAAF Patient-Reported Outcomes Consortium
 
CV_Sandra Frazilus MAY2015
CV_Sandra Frazilus MAY2015CV_Sandra Frazilus MAY2015
CV_Sandra Frazilus MAY2015
 
Critical Path Initiative Challenges
Critical  Path  Initiative  ChallengesCritical  Path  Initiative  Challenges
Critical Path Initiative Challenges
 
gkaur_Resume_CMA
gkaur_Resume_CMAgkaur_Resume_CMA
gkaur_Resume_CMA
 
Project management in clinical research sanjay akhani 8 may
Project management in clinical research sanjay akhani 8 mayProject management in clinical research sanjay akhani 8 may
Project management in clinical research sanjay akhani 8 may
 
Centralized vs. Onsite Monitoring
Centralized vs. Onsite MonitoringCentralized vs. Onsite Monitoring
Centralized vs. Onsite Monitoring
 

Viewers also liked

Viewers also liked (8)

Melissa M Cardillo Resume
Melissa M Cardillo ResumeMelissa M Cardillo Resume
Melissa M Cardillo Resume
 
Howard Holben - Resume
Howard Holben - ResumeHoward Holben - Resume
Howard Holben - Resume
 
Jeffrey Friedman RESUME NEWER VERSION 2014
Jeffrey Friedman  RESUME NEWER VERSION 2014Jeffrey Friedman  RESUME NEWER VERSION 2014
Jeffrey Friedman RESUME NEWER VERSION 2014
 
Wesley Resume
Wesley ResumeWesley Resume
Wesley Resume
 
Resume - RJ Roof_Rev1_21Oct16
Resume - RJ Roof_Rev1_21Oct16Resume - RJ Roof_Rev1_21Oct16
Resume - RJ Roof_Rev1_21Oct16
 
Resume-CV 1_May_2015
Resume-CV 1_May_2015Resume-CV 1_May_2015
Resume-CV 1_May_2015
 
DBHG- resume - 2016
DBHG- resume - 2016DBHG- resume - 2016
DBHG- resume - 2016
 
Resume.DEBROCK.2016
Resume.DEBROCK.2016Resume.DEBROCK.2016
Resume.DEBROCK.2016
 

Similar to Gina R DiGulielmo CV October 2016

B Shuler Resume
B Shuler ResumeB Shuler Resume
B Shuler Resumeantman26
 
Tasso, Vanessa, resume, 6-15
Tasso, Vanessa, resume, 6-15Tasso, Vanessa, resume, 6-15
Tasso, Vanessa, resume, 6-15Vanessa Tasso
 
Flaksman l.resume may2017
Flaksman l.resume may2017Flaksman l.resume may2017
Flaksman l.resume may2017Lidiya Flaksman
 
Anthony K Taylor CV
Anthony K Taylor CVAnthony K Taylor CV
Anthony K Taylor CVAKTaylor
 
Anthony K Taylor CV
Anthony K Taylor CVAnthony K Taylor CV
Anthony K Taylor CVAKTaylor
 
2014 ne conference presentation by rick calabrese
2014 ne conference presentation by rick calabrese2014 ne conference presentation by rick calabrese
2014 ne conference presentation by rick calabreselewiecasey
 
Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conf...
Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conf...Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conf...
Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conf...akrumenaker
 
CV_Clin_Reshma 24 Jan 17
CV_Clin_Reshma 24 Jan 17CV_Clin_Reshma 24 Jan 17
CV_Clin_Reshma 24 Jan 17Reshma Rudolph
 
Anthony K Taylor CV
Anthony K Taylor CVAnthony K Taylor CV
Anthony K Taylor CVAKTaylor
 
Resume Stephen Jones. 2015
Resume Stephen Jones. 2015Resume Stephen Jones. 2015
Resume Stephen Jones. 2015Stephen Jones
 
Protocol Design & Development: What You Need to Know to Ensure a Successful S...
Protocol Design & Development: What You Need to Know to Ensure a Successful S...Protocol Design & Development: What You Need to Know to Ensure a Successful S...
Protocol Design & Development: What You Need to Know to Ensure a Successful S...Brook White, PMP
 
Davidtwersky 2-2016-2
Davidtwersky 2-2016-2Davidtwersky 2-2016-2
Davidtwersky 2-2016-2David Twersky
 
MikeWard CV 7May2015
MikeWard CV 7May2015MikeWard CV 7May2015
MikeWard CV 7May2015Michael Ward
 
Linda Mulkerin CV.2016.2
Linda Mulkerin CV.2016.2Linda Mulkerin CV.2016.2
Linda Mulkerin CV.2016.2Linda Mulkerin
 
Deborah Johnson-Resume 02-01-2016
Deborah Johnson-Resume  02-01-2016Deborah Johnson-Resume  02-01-2016
Deborah Johnson-Resume 02-01-2016Deborah Johnson
 

Similar to Gina R DiGulielmo CV October 2016 (20)

B Shuler Resume
B Shuler ResumeB Shuler Resume
B Shuler Resume
 
Tasso, Vanessa, resume, 6-15
Tasso, Vanessa, resume, 6-15Tasso, Vanessa, resume, 6-15
Tasso, Vanessa, resume, 6-15
 
Flaksman l.resume may2017
Flaksman l.resume may2017Flaksman l.resume may2017
Flaksman l.resume may2017
 
pc15147_brochure
pc15147_brochurepc15147_brochure
pc15147_brochure
 
Anthony K Taylor CV
Anthony K Taylor CVAnthony K Taylor CV
Anthony K Taylor CV
 
Anthony K Taylor CV
Anthony K Taylor CVAnthony K Taylor CV
Anthony K Taylor CV
 
BAVAS Resume_2
BAVAS Resume_2BAVAS Resume_2
BAVAS Resume_2
 
2014 ne conference presentation by rick calabrese
2014 ne conference presentation by rick calabrese2014 ne conference presentation by rick calabrese
2014 ne conference presentation by rick calabrese
 
Maryann-Tompkins
Maryann-TompkinsMaryann-Tompkins
Maryann-Tompkins
 
Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conf...
Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conf...Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conf...
Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conf...
 
CV_Clin_Reshma 24 Jan 17
CV_Clin_Reshma 24 Jan 17CV_Clin_Reshma 24 Jan 17
CV_Clin_Reshma 24 Jan 17
 
Anthony K Taylor CV
Anthony K Taylor CVAnthony K Taylor CV
Anthony K Taylor CV
 
Resume Stephen Jones. 2015
Resume Stephen Jones. 2015Resume Stephen Jones. 2015
Resume Stephen Jones. 2015
 
Resume 03-31-2015
Resume 03-31-2015Resume 03-31-2015
Resume 03-31-2015
 
Protocol Design & Development: What You Need to Know to Ensure a Successful S...
Protocol Design & Development: What You Need to Know to Ensure a Successful S...Protocol Design & Development: What You Need to Know to Ensure a Successful S...
Protocol Design & Development: What You Need to Know to Ensure a Successful S...
 
Resume_17Apr15
Resume_17Apr15Resume_17Apr15
Resume_17Apr15
 
Davidtwersky 2-2016-2
Davidtwersky 2-2016-2Davidtwersky 2-2016-2
Davidtwersky 2-2016-2
 
MikeWard CV 7May2015
MikeWard CV 7May2015MikeWard CV 7May2015
MikeWard CV 7May2015
 
Linda Mulkerin CV.2016.2
Linda Mulkerin CV.2016.2Linda Mulkerin CV.2016.2
Linda Mulkerin CV.2016.2
 
Deborah Johnson-Resume 02-01-2016
Deborah Johnson-Resume  02-01-2016Deborah Johnson-Resume  02-01-2016
Deborah Johnson-Resume 02-01-2016
 

Gina R DiGulielmo CV October 2016

  • 1. GINA R. DIGUGLIELMO Long Valley, NJ | 862.452.1949 | ginadiguglielmo@comcast.net CAREER HIGHLIGHTS  Managed budgets of up to $10MM and trials of up to 1,300 Pts.  Developed R&D training content utilized by thousands of individuals across US, Europe, and Emerging Markets.  Lead Process Improvement Initiatives that reduced time by 50% and resourcing costs by 30%.  Business Leader on initiatives that increased user productivity by 25% and compliance to regulators by 80%.  Developed training content for off-shoring, and global clinical operations across 20 countries. EXPERIENCE Pharmaceutical & Healthcare Consultants Inc., Long Valley, NJ Owner / Independent Consultant March 2011 – Present • Independent Clinical Research Consultant for Pharmaceutical, Biotech, Device, Consumer, and Clinical Research Organizations (CROs); specializing in Clinical Research Operations and Project Management. • Managed 5 direct reports and budgets of up to $1MM for studies of up to 400 participants. • Execute short and long term assignment in areas of clinical development and clinical operations. • Expertise: Project management, trial recruitment, budget management, trial metrics, training, vendor management, process improvement initiatives, Key Opinion Leader (KOL) development Novartis Pharmaceuticals, East Hanover, NJ May 2004 – February 2011 Novartis Global Clinical Development & Medical Affairs Drug Safety & Epidemiology Associate Director Medical Safety Operations November 2009 – February 2011 • Served as Project leader on process improvement projects for clinical drug safety operations; reduced resourcing costs by 30% and time by 50% while increasing user productivity by 25% and compliance to regulators by 80%. • Managed global cross functional teams of 2-20. • Led off-shoring activities for all products requiring ASR/DSUR; approximately 80 compounds. • Developed and conducted training programs for medical safety staff and other relevant line functions within Clinical Development and Novartis Pharma worldwide; trained groups of 200+. • Designed roll-out strategies, training, and corporate communications on project initiatives reaching thousands of R&D employees in 16 countries. • Identified regulatory deficiencies in cross-functional clinical safety documents; SOPs, and databases • Evaluated processes, SOPs, tools and databases to identify potential improvements for changes in global regulatory requirements and corporate initiatives. • Updated SOPs, guidance documents, tools, manuals, and training guides for global initiatives. • Liaised with Clinical & Safety VPs to ensure continuous improvement of activities through knowledge sharing and integration of learning. • Led outsourcing initiative of medical writing and document Quality Control (QC) to Novartis India. • Identified, evaluated, and managed CROs, vendors, KOLs, and consultants for process improvement initiatives. • Identified appropriate external medical advisors to review Risk Management of Novartis products. • Designed, implemented, and developed meeting content and presentations for Advisory Board meetings
  • 2. GINA R. DIGUGLIELMO Long Valley, NJ | 862.452.1949 | ginadiguglielmo@comcast.net • Assigned Projects : Annual Safety Reports (ASR); Development Safety Update Report (DSUR); Hepatotoxicity Guidelines & Data Collection Tools; Novartis Advisory Boards for Optimizing Safety Risk Management Novartis Global Clinical Development & Medical Affairs Integrated Medical Safety Director Integrated Safety, Methods, and Innovation February 2008- October 2009 • Promoted to Project Leader on clinical and safety document process improvement initiatives. • Identified and evaluated process, tool, and database deficiencies; collaborated with cross functional teams and subject matter experts to develop solutions. • Presented evaluations and proposed solutions to senior leadership at board meetings. • Led assigned project teams on initiatives to develop, pilot, and implement new processes, methodology, and tools to support clinical and drug safety document compilation. • Developed, conducted, and implemented training programs for medical safety staff and other relevant line functions within US and Global Clinical Development on new processes, documents, tools and methods • Liaised with Therapeutic Area VPs to ensure continuous improvement of activities through knowledge sharing and integration of learning. • Developing roll-out strategies and distributing corporate communications on project initiatives throughout the global organization. • Supported the establishment of SOPs, KPIs, metrics, quality standards, and associated monitoring tools to ensure compliance and quality management of redesigned processes. Novartis Clinical Development & Medical Affairs - Arthritis, Bone, GI, Urology, Neuroscience, Ophthalmic Associate Director Project Management & Strategic Planning March 2006 - February 2008 • Promoted to Associate Director Project Management for US Phase I-IV trials on Arthritis, Osteoporosis, Herpes, Parkinson’s disease, Alzheimer’s Disease, Muckle-Wells Syndrome, Macular Degeneration, and various GI indications. • Managed the feasibility and evaluation of new clinical programs, agreement of project timelines & deliverables, investigator selection, resources assessment, budget management and tracking, and troubleshooting of study issues; escalated project changes to senior management. • Liaised between global and local clinical trial operations groups, therapeutic area physicians, field scientific operations, marketing, health economics, statistics, data management, and other departments. • Planned, managed, and coordinated project team activities to ensure that US trials met or exceeded objectives. • Developed strategic US recruitment plans to ensure that the US patient commitments were met. • Created New Ophan indications and best practice guides for recruitment in niche indications. • Designed and evaluated CRO & vendor proposals, contracts, budget, and deliverables. • Presented project updates to senior management at US and Global Therapeutic Area Operation meetings, International Project Teams, Therapeutic Area Boards, and Clinical Operation Review meetings. • Departmental Responsibilities: Train & mentor Project Managers and Local Trial Leaders on operational aspects of clinical projects & processes; Super user and trainer for Master Investigator Database (MIDB); Project team lead on CRA development plan initiatives; Project team lead on trial feasibility task force; Project Lead for GI & NS Medical Product Teams; US Clinical Operation Lead for Zelnorm adjudication and SAE reconciliation project for FDA recall Novartis US Clinical Development & Medical Affairs - Arthritis, Bone, GI, Urology Project Manager May 2004- February 2006 • Recruited to lead as Clinical Operations Project Manager for US Phase I-IV trials on Arthritis, Osteoporosis, Herpes, and various GI indications.
  • 3. GINA R. DIGUGLIELMO Long Valley, NJ | 862.452.1949 | ginadiguglielmo@comcast.net • Led the feasibility and evaluation of new clinical programs, agreement of project timelines and deliverables, investigator selection, resources assessment, budget management and tracking, and troubleshooting of study issues; escalated project changes to senior management. • Liaised between global and local clinical trial operations groups, therapeutic area physicians, field scientific operations, marketing, health economics, statistics, data management, and other departments. (Project Manager Continued) • Planned, managed, and coordinated project team activities to ensure that US trials met or exceeded objectives. • Developed strategic US recruitment plans to ensure that the US patient commitments were met. • Designed and evaluated CRO and vendor proposals, contracts, budget, and deliverables. • Presented project updates at US and Global Therapeutic Area Operation meetings, International Project Teams, Therapeutic Area Boards, and Clinical Operation Review meetings. • Departmental Responsibilities: Train and mentor Project Managers and Local Trial Leaders on operational aspects of clinical projects & processes; Project team member for developing the Master Investigator Database (MIDB); Project team member on developing the Project Manager workload resource tool; Project Lead for GI Medical Product Teams Ethicon, Inc. (a division of Johnson & Johnson) – Somerville, NJ Global Medical Affairs Senior Project Manager - Sutures, Needles, Mesh, Dermabond, Endoscopic Vessel Harvest Products October 2002 – April 2004 • Led Global Project Management for pre/post-marketing studies on Ethicon and Cardiovations products across the US, EU, South Africa, and China. • Managed studies regulated under IDE, 510k, PMA, and European registrations. • Designed protocols for new indications, marketing claims, and next generation medical devices/surgical products. • Collaborated with product engineers, veterinarians, marketing, sales, and statistics to develop desired outcomes. • Developed Protocols, CRFs, Study Guides, and other relevant documents for assigned trials. • Designed and initiated product packaging/shipping, database and statistical plans. • Evaluated, identified, and managed CROs for the conduct of clinical studies. • Prepared and negotiated contracts and budgets with CROs, Consultants, and KOL Surgeons. • Ensured vendor adherence to contracts, budgets, timelines, and regulations. • Collaborated with statisticians to format safety and efficacy listings, tables, and figures for clinical data to be published and/or submitted to the US and Global Health Authorities. • Departmental responsibilities: Project team member for developing the departmental Lean Process Map (Process Excellence/Six Sigma); Project team member on the Clinical Trial Document Management System integration (CTDMS/TrialMinder® ) Bayer Consumer Care – Morristown, NJ Medical Affairs & Clinical Research Manager, Clinical Research – Aspirin, Aleve, and Alka-Seltzer October 2000 - October 2002 • US Clinical Manager for global Phase I-IV Analgesic and Effervescent product lines, each generating $1B+ in sales. • Designed protocols for new indications, new formulations, and marketing claims for Aspirin and Alka-Seltzer (base brands and line extensions). • Designed and implemented Pharmacokinetic Phase I inpatient studies. • Developed Protocols, CRFs, Study Guides, and other relevant documents for assigned trials. • Designed and Set-up product packaging/shipping, database and statistical plans. • Evaluated, identified, and managed CROs for the conduct of clinical studies. • Prepared and negotiated contracts and budgets with CROs, Consultants, Labs, and Statisticians • Ensured vendor adherence to contracts, budgets, timelines, and regulations.
  • 4. GINA R. DIGUGLIELMO Long Valley, NJ | 862.452.1949 | ginadiguglielmo@comcast.net • Collaborated with statisticians to format safety and efficacy listings, tables, and figures for clinical data to be published and/or submitted to the US and Global Health Authorities. • Departmental Responsibilities: Develop clinical operation strategies; Write/amend SOPs; Project team member for the implementation of Documentum; Project team member for the evaluation of Web-based clinical trials software systems; Develop guidelines and procedures for departmental training guides Pharmaceutical & Healthcare Consultants – Walworth, NY Owner / Independent Clinical Research Consultant January 1999 – October 2000 • Hired to serve as Regional Project Manager/Consultant for CRO and Pharmaceutical Companies. • Managed all areas of clinical research, including but not limited to Protocol development, CRF design, investigator selection, SAE compilation/tracking, Study Manual development, and QA auditing. • Managed and trained field CRAs; conducted performance evaluations, monitored and assessed work load issues, and reviewed and approved Monitoring and Expense reports. • Therapeutic Areas/Indications: Cardiology, Endocrinology, Diabetes, Anti-Obesity, Hypertension for Phase II-III Covance , Princeton, NJ Regional Monitoring Network – Clinical Research – Based in Naples, FL Sr. Regional Clinical Research Associate/Project Lead /Manager June 1994 – January 1999 • Trained and supervised Regional CRAs for a given project, and for the site management of clinical trials in Florida. • Managed of all aspects of clinical research for assigned region including, but not limited to budgets, study supplies, SAEs, CRFs, Data Management, QA audits, investigator site selection, initiating, monitoring, and close-outs of studies on a variety of therapeutic agents. • Maintained regular communication with project teams and sponsors. • Project Responsibilities: US Phase I-IV trials within the following Indications and Diseases - Cardiology, Neurology, Pulmonology, Endocrinology, Rheumatology, Oncology, Osteoporosis, COPD, Diabetes, Anti-Obesity, Influenza, CHF, Hypertension, Post-Menopausal/HRT, Parkinson’s Disease, Alzheimer’s Disease, Stroke, HA/Migraine, and Pain Management for Cancer and Chronic Back Pain • Departmental Responsibilities: Train and mentor Regional CRAs; Review and approve monitoring reports; develop training manuals and guidelines for regional staff; develop liaison relationships with therapeutic project teams and sponsors Hoffmann-La Roche, Nutley, NJ International Clinical Research – Therapeutic Area- CNS Sr. Clinical Research Associate July 1991 - June 1994 • Coordinated and managed diverse aspects of Global Clinical Trials for Parkinson’s Disease studies Phases I-III. • Organized and participated in the initiation, monitoring, and closeout of global studies. • Collected, reviewed, and validated data generated to ensure accuracy and compliance with study protocols. • Designed and coordinated drug packaging and distribution for US and Global clinical trials • Collaborated on protocol and case report development. • Developed and designed patient brochures, press releases, and consent forms. • Supported the planning and execution of multi-center meetings; led all presentation activities. • Prepared efficacy results and data for inclusion in NDA submissions. • Aided medical monitor in Adverse Event tracking and coding in the ClinTrace Database. • Departmental Responsibilities: Train and mentor junior CRAs on Parkinson trials and departmental policies; Project team member that redesigned CRF templates and forms to streamline clinical trial data entry processes; Project team member on pilot Electronic Data Capture (EDC) fax scanning system
  • 5. GINA R. DIGUGLIELMO Long Valley, NJ | 862.452.1949 | ginadiguglielmo@comcast.net Hoffmann-La Roche - Nutley, NJ Pharmaceutical Research & Quality Control – Research Products & Biotechnology Associate Scientist - R&D April 1989 - June 1991 Assistant Scientist – QC June 1988 - April 1989 • Associate Scientist in R&D - Developed, optimized, and validated analytical methods for testing a variety of developmental drug candidates. Analyzed clinical supplies using analytical instrumentation. Collected and evaluated data and procedures for inclusion in IND/NDA submissions and in the USP. Prepared written procedures and protocols to support IND/NDA submissions. • Assistant Scientist in QC - Ensured the quality and purity of marketed dosage forms. Monitored the stability of marketed pharmaceutical products. Performed testing and evaluated data from analytical methods to ensure product’s release for human consumption. EDUCATION BS, Chemistry, Fordham University, Bronx, NY CERTIFICATIONS Project Management Certification Course, George Washington University, 2005 – 2007 Green Belt, Lean Methodology, J&J Process Excellence/Six Sigma, 2003 Certified Clinical Research Associate, Certification Number A98-259, ACRP, 1998 – 2006 Licensed Realtor, NJ Department of Banking & Insurance, 2011 – Present Real Estate Sales Training, Weichert University, 2011 PROFESSIONAL MEMBERSHIPS Drug Information Association (DIA), 1991 – Present Association of Clinical Research Professionals (ACRP), 1991 – 2006 Fordham University Alumni Club, 1988 – Present PUBLICATIONS Effect of Lazabemide on the Progression of Disability in Early Parkinson's Disease Annals of Neurology – July 1996 COMPUTER PROFICIENCIES Microsoft Excel, Word, PowerPoint, Outlook & Visio
  • 6. GINA R. DIGUGLIELMO Long Valley, NJ | 862.452.1949 | ginadiguglielmo@comcast.net Hoffmann-La Roche - Nutley, NJ Pharmaceutical Research & Quality Control – Research Products & Biotechnology Associate Scientist - R&D April 1989 - June 1991 Assistant Scientist – QC June 1988 - April 1989 • Associate Scientist in R&D - Developed, optimized, and validated analytical methods for testing a variety of developmental drug candidates. Analyzed clinical supplies using analytical instrumentation. Collected and evaluated data and procedures for inclusion in IND/NDA submissions and in the USP. Prepared written procedures and protocols to support IND/NDA submissions. • Assistant Scientist in QC - Ensured the quality and purity of marketed dosage forms. Monitored the stability of marketed pharmaceutical products. Performed testing and evaluated data from analytical methods to ensure product’s release for human consumption. EDUCATION BS, Chemistry, Fordham University, Bronx, NY CERTIFICATIONS Project Management Certification Course, George Washington University, 2005 – 2007 Green Belt, Lean Methodology, J&J Process Excellence/Six Sigma, 2003 Certified Clinical Research Associate, Certification Number A98-259, ACRP, 1998 – 2006 Licensed Realtor, NJ Department of Banking & Insurance, 2011 – Present Real Estate Sales Training, Weichert University, 2011 PROFESSIONAL MEMBERSHIPS Drug Information Association (DIA), 1991 – Present Association of Clinical Research Professionals (ACRP), 1991 – 2006 Fordham University Alumni Club, 1988 – Present PUBLICATIONS Effect of Lazabemide on the Progression of Disability in Early Parkinson's Disease Annals of Neurology – July 1996 COMPUTER PROFICIENCIES Microsoft Excel, Word, PowerPoint, Outlook & Visio